• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于阿尔茨海默病早期谱系纵向研究的 UPSA 简短形式的开发。

Development of an UPSA Short Form for Use in Longitudinal Studies in the Early Alzheimer's Disease Spectrum.

机构信息

Dr. Jesus J. Gomar, Litwin-Zucker Alzheimer's Disease Center, Feinstein Institute, Manhassett, NY, USA, Email:

出版信息

J Prev Alzheimers Dis. 2020;7(3):179-183. doi: 10.14283/jpad.2019.51.

DOI:10.14283/jpad.2019.51
PMID:32463071
Abstract

BACKGROUND

In individuals with only mild or very mild cognitive attenuations (i.e., so-called pre-clinical AD), performance-based measures of function may be superior to informant-based measures because of increased sensitivity, greater reliability, and fewer ceiling effects.

OBJECTIVE

We sought to determine if a performance-based measure of everyday function would demonstrate adequate psychometric properties and validity in the context of serial assessment over a one-year period in patients with Mild Cognitive Impairment (MCI) and early stage Alzheimer's disease (AD).

DESIGN

Participants were assessed with the performance-based measure at baseline, six weeks, and one year.

SETTING

A specialized center for the assessment and treatment of AD.

PARTICIPANTS

Three groups of subjects participated: a healthy subjects (HS) older cognitively intact group (N=43), an MCI group (N=20), and an AD group (N=26).

MEASUREMENTS

A three subtest short form of the UCSD Performance-Based Skills Assessment (UPSA) (called the UPSA-3) was the measure of interest. It consisted of the Communication, Planning, and Finance subtests.

RESULTS

Mixed model repeated measures were used to assess performance over time. Large group effects were present (HS>MCI>AD). Additionally, the AD and MCI groups demonstrated declines over one year, while the HS group remained stable (group x time interaction p=.11). The MCI/AD group demonstrated adequate test-retest reliability and did not demonstrate ceiling or floor effects.

CONCLUSION

Our data indicate that the UPSA-3 is suitable for clinical trials in that it has adequate ecological coverage and reasonable psychometric properties, and perhaps most importantly, demonstrates validity in serial assessments.

摘要

背景

在仅有轻度或非常轻度认知障碍(即所谓的临床前 AD)的个体中,基于表现的功能评估可能优于基于知情者的评估,因为前者具有更高的敏感性、更强的可靠性和更少的天花板效应。

目的

我们旨在确定在轻度认知障碍(MCI)和早期阿尔茨海默病(AD)患者的一年连续评估中,基于表现的日常功能评估是否具有足够的心理测量学特性和有效性。

设计

参与者在基线、6 周和 1 年均接受基于表现的评估。

地点

AD 评估和治疗的专门中心。

参与者

三组受试者参与:一组认知正常的健康受试者(HS)(N=43),一组 MCI 组(N=20),一组 AD 组(N=26)。

测量

UCSD 基于表现的技能评估(UPSA)的三个子测试短形式(称为 UPSA-3)是感兴趣的测量方法。它包括沟通、规划和财务三个子测试。

结果

混合模型重复测量用于评估随时间的表现。存在较大的组间效应(HS>MCI>AD)。此外,AD 和 MCI 组在一年内表现出下降,而 HS 组保持稳定(组间时间交互作用 p=.11)。MCI/AD 组表现出足够的测试-重测可靠性,并且没有表现出天花板或地板效应。

结论

我们的数据表明,UPSA-3 适合临床试验,因为它具有足够的生态覆盖范围和合理的心理测量学特性,也许最重要的是,在连续评估中表现出有效性。

相似文献

1
Development of an UPSA Short Form for Use in Longitudinal Studies in the Early Alzheimer's Disease Spectrum.用于阿尔茨海默病早期谱系纵向研究的 UPSA 简短形式的开发。
J Prev Alzheimers Dis. 2020;7(3):179-183. doi: 10.14283/jpad.2019.51.
2
Accuracy and Psychometric Properties of the Brazilian Version of the Montreal Cognitive Assessment as a Brief Screening Tool for Mild Cognitive Impairment and Alzheimer's Disease in the Initial Stages in the Elderly.《蒙特利尔认知评估巴西版作为老年人轻度认知障碍和阿尔茨海默病初始阶段简易筛查工具的准确性和心理测量学特性》
Dement Geriatr Cogn Disord. 2019;47(4-6):366-374. doi: 10.1159/000501308. Epub 2019 Aug 29.
3
Performance-based measures of everyday function in mild cognitive impairment.轻度认知障碍患者日常功能的基于表现的测量。
Am J Psychiatry. 2010 Jul;167(7):845-53. doi: 10.1176/appi.ajp.2010.09050692. Epub 2010 Apr 1.
4
The Montreal Cognitive Assessment After Omission of Hearing-Dependent Subtests: Psychometrics and Clinical Recommendations.省略听力依赖测试后的蒙特利尔认知评估:心理计量学和临床建议。
J Am Geriatr Soc. 2019 Aug;67(8):1689-1694. doi: 10.1111/jgs.15940. Epub 2019 Apr 24.
5
Development and cross-validation of the UPSA short form for the performance-based functional assessment of patients with mild cognitive impairment and Alzheimer disease.用于基于表现的轻度认知障碍和阿尔茨海默病患者功能评估的 UPSA 简短形式的制定和交叉验证。
Am J Geriatr Psychiatry. 2011 Nov;19(11):915-22. doi: 10.1097/JGP.0b013e3182011846.
6
Psychometric Evaluation of the Neuropsychological Test Battery in Individuals with Normal Cognition, Mild Cognitive Impairment, or Mild to Moderate Alzheimer's Disease: Results from a Longitudinal Study.认知正常、轻度认知障碍或轻度至中度阿尔茨海默病个体的神经心理测试组合的心理计量学评估:一项纵向研究的结果。
J Prev Alzheimers Dis. 2018;5(4):236-244. doi: 10.14283/jpad.2018.31.
7
Psychometric Properties of Alzheimer's Disease Assessment Scale-Cognitive Subscale for Mild Cognitive Impairment and Mild Alzheimer's Disease Patients in an Asian Context.亚洲背景下用于轻度认知障碍和轻度阿尔茨海默病患者的阿尔茨海默病评估量表-认知子量表的心理测量特性
Ann Acad Med Singap. 2016 Jul;45(7):273-83.
8
A quick test of cognitive speed in older adults with Alzheimer's disease and mild cognitive impairment: A preliminary behavioral and brain imaging study.阿尔茨海默病和轻度认知障碍老年人认知速度的快速测试:一项初步的行为和脑影像学研究。
Psychiatry Res Neuroimaging. 2018 Oct 30;280:30-38. doi: 10.1016/j.pscychresns.2018.08.004. Epub 2018 Aug 9.
9
Spanish version of the Mattis Dementia Rating Scale-2 for early detection of Alzheimer's disease and mild cognitive impairment.马特氏痴呆评定量表-2 的西班牙语版本,用于早期发现阿尔茨海默病和轻度认知障碍。
Int J Geriatr Psychiatry. 2018 Jun;33(6):832-840. doi: 10.1002/gps.4707. Epub 2017 Mar 23.
10
Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.帕金森病与阿尔茨海默病中的轻度认知障碍。
Parkinsonism Relat Disord. 2016 Jun;27:54-60. doi: 10.1016/j.parkreldis.2016.04.007. Epub 2016 Apr 9.

引用本文的文献

1
A systematic review of performance-based functional capacity measures for use in Huntington's disease and evaluation of their suitability for clinical trials.一项关于用于亨廷顿舞蹈症的基于表现的功能能力测量方法的系统综述及其对临床试验适用性的评估。
J Huntingtons Dis. 2025 May;14(2):113-131. doi: 10.1177/18796397251330846. Epub 2025 Apr 3.
2
Novel measures of cognition and function for the AD spectrum in the Novel Measures for Alzheimer's Disease Prevention Trials (NoMAD) project: Psychometric properties, convergent validation, and contrasts with established measures.新型阿尔茨海默病预防试验(NoMAD)项目中的认知和功能指标:心理测量特性、收敛验证以及与既定指标的对比。
Alzheimers Dement. 2024 Aug;20(8):5089-5101. doi: 10.1002/alz.13757. Epub 2024 Jul 4.
3
Expectancy Does Not Predict 18-month Treatment Outcomes with Cognitive Training in Mild Cognitive Impairment.期待不能预测轻度认知障碍认知训练 18 个月的治疗结果。
J Prev Alzheimers Dis. 2024;11(1):71-78. doi: 10.14283/jpad.2023.62.
4
Computerized Games versus Crosswords Training in Mild Cognitive Impairment.轻度认知障碍中电脑游戏与填字游戏训练的对比
NEJM Evid. 2022 Dec;1(12). doi: 10.1056/evidoa2200121. Epub 2022 Oct 27.
5
Original research: longitudinal evaluation of cognitively demanding daily function using performance-based functional assessment highlights heterogeneous trajectories in cognitive and functional abilities in people with Parkinson's disease.原创研究:使用基于表现的功能评估对认知要求较高的日常功能进行纵向评估,突显了帕金森病患者认知和功能能力的异质性轨迹。
Front Neurosci. 2023 Jun 26;17:1200347. doi: 10.3389/fnins.2023.1200347. eCollection 2023.
6
Improvements in Cognitive Performance With Computerized Training in Older People With and Without Cognitive Impairment: Synergistic Effects of Skills-Focused and Cognitive-Focused Strategies.有认知障碍和无认知障碍老年人通过计算机化训练实现的认知表现改善:技能导向和认知导向策略的协同效应
Am J Geriatr Psychiatry. 2022 Jun;30(6):717-726. doi: 10.1016/j.jagp.2021.11.008. Epub 2021 Nov 21.
7
Development of novel measures for Alzheimer's disease prevention trials (NoMAD).用于阿尔茨海默病预防试验的新型措施的制定(NoMAD)。
Contemp Clin Trials. 2021 Jul;106:106425. doi: 10.1016/j.cct.2021.106425. Epub 2021 Apr 30.
8
The Computerized Functional Skills Assessment and Training Program: Sensitivity to Global Cognitive Impairment, Correlations With Cognitive Abilities, and Factor Structure.计算机化的功能技能评估和训练计划:对全球认知障碍的敏感性、与认知能力的相关性以及因子结构。
Am J Geriatr Psychiatry. 2021 Apr;29(4):395-404. doi: 10.1016/j.jagp.2020.08.019. Epub 2020 Sep 7.